Atea Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio6.13
P/S Ratio2.1170.97
P/B Ratio0.650.460.631.056.30
Price/Tangible Book0.650.460.631.056.30
Price/FCF11.63
Price/OCF11.63
Enterprise Value Ratios
EV/Revenue72.42
EV/FCF11.87
Profitability & Returns
Return on Equity (ROE)-0.34%-0.23%-0.17%0.19%-0.04%
Return on Assets (ROA)-0.16%-0.12%-0.10%0.11%-0.02%
Return on Capital Employed (ROCE)-0.30%-0.21%-0.17%0.19%-0.02%
Leverage & Solvency Ratios
Debt/Equity0.000.000.010.00
Debt/EBITDA0.00
Liquidity Ratios
Current Ratio24.8518.2435.7713.582.73
Quick Ratio24.4418.0435.0013.442.71
Efficiency Ratios
Asset Turnover0.430.11
Yield & Distribution Ratios
Earnings Yield-0.60%-0.53%-0.29%0.16%0.00%
FCF Yield-0.48%-0.34%-0.31%-0.12%0.09%
Buyback Yield-0.01%0.00%0.06%-3.09%-1.14%